Piper Sandler Downgrades BioDelivery Sciences Intl to Neutral, Raises Price Target to $5.6
Piper Sandler analyst David Amsellem downgrades BioDelivery Sciences Intl (NASDAQ:BDSI) from Overweight to Neutral and raises the price target from $5 to $5.6.
Mid-Afternoon Market Update: Nasdaq Turns Lower; Dow Dips 350 Points
US stocks traded lower on Monday with the Nasdaq turning negative toward the end of trading amid rising tensions on the border of Russia and Ukraine. The United States said Russia had amassed troops on the Ukrainian border to launch an invasion, Reuters reported.
Mid-Day Market Update: Gold Rises 1%; BioDelivery Sciences International Shares Spike Higher
US stocks remained mixed midway through trading on Monday amid rising tensions on the border of Russia and Ukraine. The United States said Russia had amassed troops on the Ukrainian border to launch an invasion, Reuters reported.
Mid-Morning Market Update: US Stocks Mixed Amid Russia-Ukraine Tensions
US stocks opened on a mixed note this morning amid rising tensions on the border of Russia and Ukraine. The United States said Russia had amassed troops on the Ukrainian border to launch an invasion, Reuters reported.
65 Biggest Movers From Yesterday
Gainers
Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated global provider of energy infrastructure.
